Skip to main content

Advertisement

SpringerLink
Log in

Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Peripheral arterial disease (PAD) is an under-recognized complication of diabetes. Recently, prevalence estimates in patients with diabetes over 50 years of age have been placed at 25% to 30%. The main reason for under-reporting is the largely asymptomatic nature of PAD in diabetes. Nonetheless, it is important to diagnose PAD because it is a marker of systemic atherosclerosis with excess cardiovascular risk, and it may identify a patient who may develop progressive disability and risk of limb loss. The most sensitive and specific diagnostic tool is an ankle-brachial index. Imaging studies are performed in patients who are candidates for revascularization. The most durable and effective revascularization procedure for PAD in diabetes is surgical bypass with saphenous vein as the conduit. Endovascular interventions are best used in patients with proximal disease with short-segment stenoses. The indications for revascularization have been immutable for decades, namely rest pain, ischemic ulceration, or gangrene. Presently, clinicians would include "selected" patients with intermittent claudication who have disabling symptoms and proximal disease above the inguinal ligament.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Dormandy JA, Rutherford RB: Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Concensus (TASC). J Vasc Surg 2000, 31(1 Pt 2):S1-S296.

    Article  PubMed  CAS  Google Scholar 

  2. Kannel WB: Risk factors for atherosclerotic cardiovascular outcomes in different arterial territories. J Cardiovasc Risk 1994, 1:333–339.

    Article  PubMed  CAS  Google Scholar 

  3. Hirsch AT, Criqui MH, Treat-Jacobson D: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317–1324.

    Article  PubMed  CAS  Google Scholar 

  4. Elhadd TA, Jung RT, Stonebridge PA, Belch JF: Pilot study of prevalence of asymptomatic peripheral arterial occlusive disease in patients with diabetes attending a hospital clinic. Practical Diabetes Int 1999, 16:163–166.

    Article  Google Scholar 

  5. Beckman JA, Creager MA, Libby P: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287:2570–2581.

    Article  PubMed  CAS  Google Scholar 

  6. Schneider DL, Sobel BE: Diabetes and Thrombosis. Edited by Johnstone M, Veves A. Totowa, NJ: Humana Press; 2001.

    Google Scholar 

  7. LoGerfo FW, Coffman JD: Current concepts. Vascular and microvascular disease of the foot in diabetes. Implications for foot care. N Engl J Med 1984, 311:1615–1619.

    Article  PubMed  CAS  Google Scholar 

  8. Dolan NC, Liu K, Criqui MH, et al.: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care 2002, 25:113–120.

    Article  PubMed  Google Scholar 

  9. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee [no authors listed]. Lancet 1996, 348:1329-1339.

  10. Weitz JI, Byrne J, Clagett GP, et al.: Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 1996, 94:3026–3049.

    PubMed  CAS  Google Scholar 

  11. American Diabetes Association: Peripheral arterial disease in people with diabetes. Diabetes Care 2003, 26:3333–3341. An American College of Cardiology and American Diabetes Association initiative of experts with a consensus statement on the epidemiology, biology, assessment, and management of PAD in patients with diabetes.

    Article  Google Scholar 

  12. Teodorescu VJ, Chen C, Morrissey N, et al.: Detailed protocol of ischemia and the use of noninvasive vascular laboratory testing in diabetic foot ulcers. Am J Surg 2004, 187:75S-80S.

    Article  PubMed  Google Scholar 

  13. Andros G, Harris RW, Dulawa LB, et al.: The need for arteriography in diabetic patients with gangrene and palpable foot pulses. Arch Surg 1984, 119:1260–1263.

    PubMed  CAS  Google Scholar 

  14. Caputo GM, Cavanagh PR, Ulbrecht JS, et al.: Assessment and management of foot disease in patients with diabetes. N Engl J Med 1994, 331:854–860.

    Article  PubMed  CAS  Google Scholar 

  15. Pomposelli FB Jr, Jepsen SJ, Gibbons GW, et al.: Efficacy of the dorsal pedal bypass for limb salvage in diabetic patients: short-term observations. J Vasc Surg 1990, 11:745–751; discussion 751–752.

    Article  PubMed  Google Scholar 

  16. Akbari CM, Pomposelli FB Jr, Gibbons GW, et al.: Lower extremity revascularization in diabetes: late observations. Arch Surg 2000, 135:452–456.

    Article  PubMed  CAS  Google Scholar 

  17. Hamdan AD, Rayan SS, Hook SC, et al.: Bypasses to tibial vessels using polytetrafluoroethylene as the solo conduit in a predominantly diabetic population. Vasc Endovascular Surg 2002, 36:59–63.

    PubMed  Google Scholar 

  18. Akbari CM, LoGerfo FW: Diabetes and peripheral vascular disease. J Vasc Surg 1999, 30:373–384.

    Article  PubMed  CAS  Google Scholar 

  19. Faries PL, LoGerfo FW, Hook SC, et al.: The impact of diabetes on arterial reconstructions for multilevel arterial occlusive disease. Am J Surg 2001, 181:251–255.

    Article  PubMed  CAS  Google Scholar 

  20. Faries PL, Brophy D, LoGerfo FW, et al.: Combined iliac angioplasty and infrainguinal revascularization surgery are effective in diabetic patients with multilevel arterial disease. Ann Vasc Surg 2001, 15:67–72.

    PubMed  CAS  Google Scholar 

  21. Ballotta E, Renon L, Toffano M, et al.: Patency and limb salvage rates after distal revascularization to unclampable calcified outflow arteries. J Vasc Surg 2004, 39:539–546.

    Article  PubMed  Google Scholar 

  22. Johnston KW, Rae M, Hogg-Johnston SA, et al.: 5-year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 1987, 2061:403–413.

    Article  Google Scholar 

  23. Palmaz JC, Laborde JC, Rivera FJ, et al.: Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc Intervent Radiol 1992, 15:291–297.

    PubMed  CAS  Google Scholar 

  24. Bosch JL, Hunink MG: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 1997, 204:87–96.

    PubMed  CAS  Google Scholar 

  25. Cambria RP, Faust G, Gusberg R, et al.: Percutaneous angioplasty for peripheral arterial occlusive disease. Correlates of clinical success. Arch Surg 1987, 122:283–287.

    PubMed  CAS  Google Scholar 

  26. Jeans WD, Cole SE, Horrocks M, Baird RN: Angioplasty gives good results in critical lower limb ischaemia. A 5-year followup in patients with known ankle pressure and diabetic status having femoropopliteal dilations. Br J Radiol 1994, 67:123–128.

    Article  PubMed  CAS  Google Scholar 

  27. van der Zaag ES, Legemate DA, Prins MH, et al.: Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial. Eur J Vasc Endovasc Surg 2004, 28:132–137.

    PubMed  Google Scholar 

  28. Lofberg AM, Karacagil S, Ljungman C, et al.: Percutaneous transluminal angioplasty of the femoropopliteal arteries in limbs with chronic critical lower limb ischemia. J Vasc Surg 2001, 34:114–121.

    Article  PubMed  CAS  Google Scholar 

  29. Gray BH, Sullivan TM, Childs MB, et al.: High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty. J Vasc Surg 1997, 25:74–83.

    Article  PubMed  CAS  Google Scholar 

  30. Saxon RR, Coffman JM, Gooding JM, et al.: Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective, randomized trial. J Vasc Interv Radiol 2003, 14:303–311.

    PubMed  Google Scholar 

  31. Parsons RE, Suggs WD, Lee JJ, et al.: Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998, 28:1066–1071.

    Article  PubMed  CAS  Google Scholar 

  32. Bolia A, Brennan J, Bell PR: Recanalisation of femoropopliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol 1989, 40:325.

    Article  PubMed  CAS  Google Scholar 

  33. Vraux H, Hammer F, Verhelst R, et al.: Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischaemia: mid-term results. Eur J Vasc Endovasc Surg 2000, 20:441–446.

    Article  PubMed  CAS  Google Scholar 

  34. Desgranges P, Boufi M, Lapeyre M, et al.: Subintimal angioplasty: feasible and durable. Eur J Vasc Endovasc Surg 2004, 28:138–141.

    PubMed  CAS  Google Scholar 

  35. Reekers JA, Kromhout JG, Jacobs MJ: Percutaneous intentional extraluminal recanalisation of the femoropopliteal artery. Eur J Vasc Surg 1994, 8:723–728.

    Article  PubMed  CAS  Google Scholar 

  36. London NJ, Srinivasan R, Naylor AR, et al.: Subintimal angioplasty of femoropopliteal artery occlusions: the long-term results. Eur J Vasc Surg 1994, 8:148–155.

    Article  PubMed  CAS  Google Scholar 

  37. Bolia A: Percutaneous intentional extraluminal (subintimal) recanalization of crural arteries. Eur J Radiol 1998, 28:199–204.

    Article  PubMed  CAS  Google Scholar 

  38. Lipsitz EC, Ohki T, Veith FJ, et al.: Does subintimal angioplasty have a role in the treatment of severe lower extremity ischemia? J Vasc Surg 2003, 37:386–391.

    Article  PubMed  Google Scholar 

  39. Duda SH, Poerner TC, Wiesinger B, et al.: Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 2003, 14:291–301.

    PubMed  Google Scholar 

  40. Sousa JE, Costa MA, Abizaid AC, et al.: Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001, 104:2007–2011.

    PubMed  CAS  Google Scholar 

  41. Sousa JE, Costa MA, Abizaid A, et al.: Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2001, 103:192–195.

    PubMed  CAS  Google Scholar 

  42. Duda SH, Pusich B, Richter G, et al.: Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation 2002, 106:1505–1509.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Diabetes Foot & Ankle Center, Hospital for Joint Diseases, 301 East 17th Street, 10003, New York, NY, USA

    Peter Sheehan MD

Authors
  1. Bart E. Muhs MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Gagne MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter Sheehan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muhs, B.E., Gagne, P. & Sheehan, P. Peripheral arterial disease: Clinical assessment and indications for revascularization in the patient with diabetes. Curr Diab Rep 5, 24–29 (2005). https://doi.org/10.1007/s11892-005-0063-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0063-7

Keywords

Search

Navigation